Q4 2018 Syros Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Quarter 4 2018 Syros Pharmaceuticals, Inc. Earnings Conference Call. (Operator Instructions) I would now like to introduce your host for today's conference, Naomi Aoki, Vice President of Corporate Communications and Investor Relations for Syros. Please go ahead.
Thank you. This morning, we issued a press release with our fourth quarter and full year 2018 financial results, along with anticipated future milestones and recent accomplishments. This release is available on the Investors & Media section of Syros' website at www.syros.com.
We will begin the call with prepared remarks by Dr. Nancy Simonian, our Chief Executive Officer; Dr. David Roth, our Chief Medical Officer; and Joe Ferra, our Chief Financial Officer. Then we will open the call for questions. Dr. Eric Olson, our Chief Scientific Officer; and Dr. Jeremy Springhorn, our Chief Business Officer,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |